CliffBio
small molecule

GABITRIL

TIAGABINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCephalon →See this company's full patent-cliff portfolio

Drug detail

Brand nameGABITRIL
Active ingredientTIAGABINE HYDROCHLORIDE
Strength6MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2005
Marketing statusDISCN

More from Cephalon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.